Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-990-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because the physicochemical and toxicological properties suggest no potential for a significant rate of absorption through the skin
- Justification for type of information:
- As stated in COMMISSION REGULATION (EU) 2016/863, amending Annexes VII and VIII to Regulation (EC) No 1907/2006:
"Recent scientific analysis of available data from in vivo acute toxicity studies have shown that substances that are not toxic via the oral route may be expected with high certainty to be also non-toxic via the dermal route. Therefore, testing those substances via the dermal route does not provide essential information for their safety assessment."
As shown in the acute oral toxicity endpoint, the substance is not toxic via the oral route. In the toxikokinetic assessment it is explained why the substance is not easily absorbed through skin, see cross-refs. below.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- calculation (if not (Q)SAR)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Calculation based on various sources and common knowledge
- Justification for type of information:
- An acute exposure of 2’400 mg/kg body weight (bw) of the substance Bos taurus, milk, pasteurized, homogenized, skimmed, fermented, spray-dried (EC 917-734-0) is considered safe in humans. Therefore, animal testing of the oral, acute toxicity of the substance is not necessary.
Reasoning:
The Swiss Food Pyramid proposes a daily consume of 200 g Yoghurt per day (BLV, 2017). Under the assumption of a water content of 86 % of yoghurt, the dry substance of yoghurt and therefore yoghurt powder is 14 % of wet weight of yoghurt (BLV, 2018). This results in a proposed intake of 28 g dry weight of yoghurt powder per day. Applied to an average person (70 kg) results in a daily intake of yoghurt of 400 mg/kg bw/day. This value represents a safe, chronic intake of yoghurt per day without adverse effects.
For the derivation of a chronic Derived No Effect Level (DNEL) for human health, the ECHA provides guidance on the extrapolation from shorter studies to chronic studies (ECHA, 2012). For the extrapolation of a sub-acute study to a chronic study ECHA proposes an assessment factor of 6 to more serious adverse effects with increasing exposure times into account. The inverse conclusion suggests that the extrapolation of a chronic duration to a sub-acute duration with a factor of 6 is also possible. In case of an acute (instead of sub-acute) duration, this extrapolation can be even considered as a conservative approach. Under these circumstances an acute exposure to yoghurt powder of 2’400 mg/kg bw can be considered safe for humans.
The same value can be assumed for the exposure of animals to yoghurt powder. Since, according to the OECD guidelines the highest tested concentrations in rats for acute oral toxicity should be 2’000 mg/kg bw, testing the acute oral toxicity of yoghurt powder is not considered necessary.
Sources:
Bundesamt für Lebensmittelsicherheit und Veterinärwesen (BLV). Fachinformation Ernährung: Milch- und Milchproduktekonsum in der Schweiz 2014/2015. März 2017.
Bundesamt für Lebensmittelsicherheit und Veterinärwesen. Schweizer Nährwertdatenbank, Lebensmittelsuche für Joghurt. State of knowledge: 04.05.2018.
European Chemicals Agency (ECHA). Guidance on information requirements and chemical safety assessment: Chapter R.8: Characterization of dose [concentration]-response for human health. Version 2.1. November 2012. - Qualifier:
- no guideline required
- Principles of method if other than guideline:
- See Field Justification for type of information
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 400 mg/kg bw
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- An acute exposure of 2’400 mg/kg body weight (bw) of the substance Bos taurus, milk, pasteurized, homogenized, skimmed, fermented, spray-dried (EC 917-734-0) is considered safe in humans.
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- not specified
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP, near guideline, published in peer reviewed literature, adequate for assessment
- Justification for type of information:
- The test material used to test the toxicological properties described in the study used for this RSS is not exactly the same as Bos taurus, milk, pasteurized, homogenized, skimmed, fermented, spray-dried. However, the process used to prepare ‘Powdered Lactobacillus helveticus-fermented milk’ (FM) is qualitatively similar to that used in the production of ‘Bos taurus, milk, pasteurized, homogenized, skimmed, fermented, spray dried’ and is based on the same natural material (cow milk) and biological production process (bacterial fermentation). The components that are additionally removed from FM, lactic acid and casein, occur naturally in milk and milk that has been naturally exposed to microorganisms and are not expected to have important toxicological effects regarding acute oral toxicity, repeated dose oral toxicity, reproduction, or genotoxicity at the concentrations present in fermented milk products. Therefore, the toxicological properties reported on this study can be used in combination with the long historical safe consumption of yogurt and yogurt-derived products by humans in a weight of evidence analysis to assess the toxicological properties of 'Bos taurus, milk, pasteurized, homogenized, skimmed, fermented, spray dried' for this endpoint.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
- Limit test:
- no
- Specific details on test material used for the study:
- Reconstituted skim milk (9%, w/w) was pasteurized and fermented with L. helveticus CM4 at 37°C for 22 h. Casein was removed by centrifugation and lactic acid was eliminated from the supernatant by electrodialysis. The residual supernatant was converted to fermented milk whey powder by using maltodextrin as a bulking agent and spray drying.
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- (Crj:CD(SD), SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:
- Age at study initiation: 6 to 7 weeks old
- Weight at study initiation: 140 to 201 g (males) and 112 to 164 g (females)
- Housing: individually in metal cages
- Diet: ad libitum pelleted CRF; Oriental Yeast Co., Ltd, or Rodent diet 5002; PMI Inc.
- Water: tap water ad libitum
- Acclimation period: 1 week
DETAILS OF FOOD AND WATER QUALITY:
Drinking water and food were routinely analyzed for contaminants. Analyses revealed no evidence of contamination that either compromised or influenced the outcome of the studies.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12h/12h - Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 2000 mg/kg bw
4000 mg/kg bw - No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- Powdered FM was suspended in water (5%, 10%, or 20%) and the suspension shaken vigorously until the contents showed no evidence of test article sedimentation.
Animals were fasted overnight prior to administration of the solution/suspension and for approximately 3 h after dosing.
Rats administered the single doses of powdered FM were observed for grossly observable clinical signs for 6 h after dosing, then once daily for 14 consecutive days. Individual animal body weights were determined on the day of dosing and on days 2, 4, 7, and 14 after dosing. On experimental day 14, all rats were anesthetized (sodium thiopental or ether anesthesia) and exsanguinated, then subjected to detailed necropsy. In the absence of abnormalities observed at necropsy, histopathology evaluations were not conducted. - Statistics:
- Quantitative data were analyzed for homogeneity of variance using Bartlett’s test (Sokal and Rohlf 1969a). Homogeneous data were subjected to one-way analysis of variance and differences between dosed and control groups were assessed for statistical significance with Dunnett’s test (Dunnett 1955). Heterogeneous data were subjected to Kruskal-Wallis’ test (Sokal and Rohlf 1969b) and differences between dosed and control groups were assessed with Dunnett’s rank test (Dunnett 1955).
- Key result
- Sex:
- male/female
- Dose descriptor:
- other: single-dose LOEL
- Effect level:
- > 4 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no mortality observed
- Clinical signs:
- no effects observed
- Body weight:
- no effects observed
- Gross pathology:
- no effects observed
- Other findings:
- A single female dosed with 4000 mg/kg powdered FM had soft stool 4 h after dosing; however, soft stools and perianal fecal smudging were observed sporadically in dosed as well as control rats throughout the 2-week, postdosing observation period.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Single-dose oral administration of 4000 mg/kg of powdered FM caused no evidence of either systemic or local toxicity in male or female rats (e.g., behavioral observations; clinical signs; food consumption; body weight gains; ophthalmologic examinations; clinical pathology [hematology, clinical chemistry]; urinalysis).
According to the considerations previously listed on the field "justification for type of information", it can be concluded that a single dose of 4000 mg/kg "Bos taurus, milk, pasteurized, homogenized, skimmed, fermented, spray-dried" (EC No. 917-734-0) would likewise not cause either systemic or local toxicity in male or female rats. - Executive summary:
The objective of this study was to assess the toxicological potential of powdered Lactobacillus helveticus–fermented milk (FM). All test articles were administered by oral gavage to male and female Sprague-Dawley rats. Specific goal of the single-dose study was to identify doses that produce evidence of systemic and/or local (i.e., gastrointestinal) toxicity (e.g., lowest-observable effect level [LOEL]). Single doses of powdered FM (2000 or 4000 mg/kg) were administered 14 days prior to study termination. No treatment regimen caused either antemortem (gross observations, body weight, and food consumption parameters) or postmortem (necropsy) evidence of either systemic or local toxicity. Under the conditions of these experiments, the single-dose LOEL of powdered FM was found to be greater than 4000 mg/kg bw.
The process used to prepare ‘Powdered Lactobacillus helveticus-fermented milk’ (FM) is qualitatively similar to that used in the production of ‘Bos taurus, milk, pasteurized, homogenized, skimmed, fermented, spray dried’ and is based on the same natural material (cow milk) and biological production process (bacterial fermentation).The components that are additionally removed from FM, lactic acid and casein, occur naturally in milk and milk that has been naturally exposed to microorganisms and are not expected to have important toxicological effects regarding acute oral toxicity, repeated oral dose toxicity, reproduction, or genotoxicity at the concentrations present in fermented milk products.
Therefore, taking into account the previous considerations, it is safe to assume that the single-dose LOEL of 'Bos taurus, milk, pasteurized, homogenized, skimmed, fermented, spray dried' would also be greater than 4000 mg/kg bw.
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
- Bioaccumulation potential:
- no bioaccumulation potential
The substance Bos taurus, milk, pasteurized, homogenized, skimmed, fermented, spray-dried (EC 917-734-0) is a UVCB substance originating from biochemical changes produced in milk by various species of bacteria or yeast, where the main constituents are raw proteins (approx. 34.1% w/w), lactose (approx. 40.3% w/w) and lactic acid (=2.5 - =5% w/w); minor constituents include water (3 – 10% w/w), raw ash (inorganic constituents) (>3 – <10% w/w), raw fat (>0.25 – <1.5% w/w), and other carbohydrates (=2 – =3% w/w). Raw ash contains calcium (=7 – =26% w/w), sodium (=0 - =13% w/w), potassium (=13 - =26% w/w) and magnesium (=0 - =13% w/w). The proteins consist mainly of caseines (80%), serum albumines, beta-lactoglobulines, immunoglobulines and lactalbumines.
After ingestion, raw proteins are generally broken down into amino acids through denaturation of the protein in the acidic environment of the stomach and hydrolysis by proteases in the intestine. They are absorbed from the intestine and distributed systemically across various compartments of the body. Since amino acids are of natural origin and form an essential part of the normal human diet, no further consideration of the toxicokinetics of raw protein is necessary
Likewise, ingested lactose is digested through the enzyme lactase, which is expressed in the brush border membrane of enterocytes in the small intestine, and cleaved into the sugar monomers, glucose and galactose which are taken up in the small intestine (Hampson et. al., 1986). Therefore, it is absorbed and distributed as glucose and galactose. Based on the long history dietary human exposure to lactose, the substance is not acute orally toxic and the evaluation of the toxicokinetics of lactose is not considered necessary. Furthermore, lactose is exempted from REACH registration requirements according to REACH Annex IV (substances included in Annex IV: sufficient information is known about these substances that they are considered to cause minimum risk because of their intrinsic properties) and can thus be considered to have non-critical properties.
Due to the low volatility (lactose: <0.1 Pa at 25°C, lactic acid: 11 Pa at 25°C) the main constituents of the substance are not present in a gaseous state and gas-phase absorption through inhalation is therefore highly unlikely at normal ambient temperatures. The 10th percentile and median size of the particles of the substance (D10 = 75.3 µm and D50 = 127.5 µm, mass based) indicates that the large majority of the particles are too big to be inhaled. If some portion of the substance should reach the respiratory tract, the main constituents could cross the alveolar and capillary membranes by a combination of active and passive uptake mechanisms. Additionally, there is human data on the respiratory effects of occupational exposure to milk powder available which, can be used as an analog to provide evidence for yoghurt powder. Although there were no signs of systemic toxicity, increased risk of nasal symptoms, wheezing, breathlessness and reduced spirometric lung function were observed; based on these findings the substance was classified as a Category 1 respiratory sensitizer.
The physical state (solid) and high molecular weight (only <100 g/mol can be readily taken up dermally) of the main constituents suggest that the substance will not be easily absorbed through skin. Additionally, the high water solubility and low log P values (-0.72 to -3.77) will further decrease the penetration into the lipid rich stratum corneum and therefore dermal absorption of the substances will be limited due to high hydrophilicity.. In a worst-case approach, based on the classification of the substance L (+) Lactic Acid (CAS-No. 79-33-4, EC-No. 201-196-2), Bos Taurus, milk, fermented, spray-dried (EC 917-734-0) was classified as “Skin Irritation Cat. 2” (H315). A damaged skin surface, induced through the substance, may enhance the penetration of the substance.
Sources:
Hampson, D., Kidder, DE (1986). Influence of creep feeding and weaning on brush border enzyme activities in the piglet small intestine. Res Vet Sci. 40(1):24-31.
Boiling point lactic acid: Haynes, W.M. (ed.). CRC Handbook of Chemistry and Physics. 95th Edition. CRC Press LLC, Boca Raton: FL 2014-2015, p. 3-336
Vapour pressure Lactic acid: Yaws CL; Handbook Chem Compd Data Process Saf, Houston, TX: Gulf Publishing, p. 33 (1997).
Log P Lactic acid: Hansch, C., Leo, A., D. Hoekman. Exploring QSAR - Hydrophobic, Electronic, and Steric Constants. Washington, DC: American Chemical Society
A toxicokinetic assessment based on the physical properties (see ECHA Guidance on Information Requirements and Chemical Safety Assessment, R7c, version 3.0, June 2017) and toxicity data was performed. NOTE: this is mostly a generic assessment based on general statements in the guidance document that are derived from physical parameters.
Data source
Materials and methods
Results and discussion
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.